Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04444726Completed
Randomised, open-label trial of psoralen in atopic dermatitis (AD), sponsored by Cairo University. Primary endpoint: Patient Oriented Eczema Measure at 8 weeks. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04444726.